Histamine-selective H3 receptor ligands and cognitive functions: an overview
Vohora, D.
Idrugs the Investigational Drugs Journal 7(7): 667-673
2004
ISSN/ISBN: 1369-7056 PMID: 15243869 Document Number: 568915
This review presents a link between histamine and cognition and provides an overview on the effect of histamine and selective ligands of histamine receptors on experimental models for learning, memory and cognitive functions, with a special focus on recently developed H(3) receptor ligands. Studies suggest a tremendous potential for H(3) antagonists in cognitive function disorders.
Document emailed within 1 workday
Related Documents
Nevalainen, T. 2014: Recent development of CB2 selective and peripheral CB1/CB2 cannabinoid receptor ligands Current Medicinal Chemistry 21(2): 187-203Smolders, I. 2005: Differential glutamatergic modulation of monoamine release in the limbic lobe by selective anticonvulsant ionotropic and metabotropic glutamate receptor ligands Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 67(5-6): 371-398
Poizot, A.; Dumez, D.; Ferrandon, P.; Lefournier, C.; Michel, A.; Armstrong, J.M. 1986: Animal pharmacology of the selective histamine H1-receptor antagonist tazifylline Arzneimittel-Forschung 36(4): 695-702
Cieślewicz, G.; Gondorowicz, K.; Grzelewska-Rzymowska, I.; Rozniecki, J.; Wojciechowska, B. 1992: Effect of loratadine--selective antagonist of histamine (H1) receptor--on allergen-induced bronchoconstriction in atopic asthmatics Pneumonologia i Alergologia Polska 60(11-12): 11-15
Eriks, J.C.; van der Goot, H.; Timmerman, H. 1993: New activation model for the histamine H2 receptor, explaining the activity of the different classes of histamine H2 receptor agonists Molecular Pharmacology 44(4): 886-894
Holroyde, M.C.; Eyre, P. 1978: Histamine enhances anaphylactic histamine release from bovine lung and leukocytes via histamine H2-receptor Journal of Pharmacology and Experimental Therapeutics 204(1): 183-188
Cieślewicz, G.; Gondorowicz, K.; Grzelewska-Rzymowska, I.; Rozniecki, J. 1995: Effect of loratadine, selective antagonist of histamine H1 receptors, on histamine-induced bronchoconstriction Pneumonologia i Alergologia Polska 63(5-6): 281-285
Li, G.-c.; Zhang, B.-l.; Xia, J.-y.; Fang, Z.-J. 2015: Synthesis and receptor binding assay of indolin-2-one derivatives as dopamine D4 receptor ligands Die Pharmazie 70(8): 511-514
Ashwell, J.D.; Fox, B.S.; Schwartz, R.H. 1987: Use of a receptor competition assay to explore the interaction of the T cell antigen-specific receptor with its ligands Federation Proceedings 46(1): 183-189
Knoflach, F.; Drescher, U.; Scheurer, L.; Malherbe, P.; Mohler, H. 1993: Full and partial agonism displayed by benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes Journal of Pharmacology and Experimental Therapeutics 266(1): 385-391
Saito, Y. 2001: Searching for neurotransmitters as cognate ligands of orphan G protein-coupled receptor: finding receptor for melanin-concentrating hormone Nihon Shinkei Seishin Yakurigaku Zasshi 21(3): 77-82
Laube, F. 2009: Mannose-6-phosphate/insulin-like growth factor-Ii receptor in human melanoma cells: effect of ligands and antibodies on the receptor expression Anticancer Research 29(4): 1383-1388
Grund, V.R.; Goldberg, N.D.; Hunninghake, D.B. 1975: Histamine receptors in adipose tissue: involvement of cyclic adenosine monophosphate and the H2-receptor in the lipolytic response to histamine in isolated canine fat cells Journal of Pharmacology and Experimental Therapeutics 195(1): 176-184
Anzini, M.; Cappelli, A.; Vomero, S.; Botta, M.; Cagnotto, A. 1990: 5-HT and benzodiazepine receptor ligands. III. Synthesis and receptor affinities of 1,2,4-triazolo[4',3':1,6]pyridazino[4,5-b]quinoline and 2,3-dihydro-9-phenyl-1H-pyrrolo[3,4-b]quinoline-1-one derivatives Farmaco 45(11): 1169-1179
Spetea, M.; Asim, M.Faheem.; Noha, S.; Wolber, G.; Schmidhammer, H. 2013: Current κ opioid receptor ligands and discovery of a new molecular scaffold as a κ opioid receptor antagonist using pharmacophore-based virtual screening Current Pharmaceutical Design 19(42): 7362-7372
Cascieri, M.A.; Chicchi, G.G.; Freidinger, R.M.; Colton, C.D.; Perlow, D.S.; Williams, B.; Curtis, N.R.; McKnight, A.T.; Maguire, J.J.; Veber, D.F. 1986: Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site Molecular Pharmacology 29(1): 34-38
Maj, J.; Rogóz, Z.; Skuza, G. 1993: Influence of 1,3-di-o-tolylguanidine and rimcazole, selective sigma ligands, on apomorphine and neuroleptic effects Polish Journal of Pharmacology 45(3): 327-330
Nicholas, R.A.; Watt, W.C.; Lazarowski, E.R.; Li, Q.; Harden, K. 1996: Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor Molecular Pharmacology 50(2): 224-229
Schäcke, H.; Rehwinkel, H. 2004: Dissociated glucocorticoid receptor ligands Current Opinion in Investigational Drugs 5(5): 524-528
Pertwee, R.G. 1999: Pharmacology of cannabinoid receptor ligands Current Medicinal Chemistry 6(8): 635-664